Dr Jack Tan

President of Asian Pacific Society of Cardiology

Dr Kenji Inoue

Associate Professor, Department of Cardiology, Juntendo University Nerima Hospital, Japan

Dr Chanchal Chandramouli

Clinical Research Fellow, National Heart Centre Singapore

Dr David Lye

Director of Infectious Disease Research and Training Office, National Centre for Infectious Diseases Singapore

Home > Latest Perspectives > APSC Consensus > APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19

APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19

20 August 2020

KEY TAKEAWAYS

The Asia-Pacific Society of Cardiology (APSC) high-sensitivity troponin T (hs-TnT) consensus recommendations and rapid algorithm were developed to provide guidance for healthcare professionals
ED physicians in APAC region can now triage individuals with symptoms suggestive of ACS according to the APSC Consensus on hs TnT.
The APSC consensus recommendations are developed keeping both safety of patients in mind and to improve efficiency in healthcare.

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.

28 March 2023

Prof Alexandre Mebazaa

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021

Dr James L Januzzi